Mersana Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Mersana Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mersana Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mersana Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $4.4M | 2.4M | 1.89 |
| 2024-06-30 | $4.0M | 2.0M | 2.01 |
| 2024-03-31 | $6.4M | 1.4M | 4.48 |
| 2023-12-31 | $183k | 79k | 2.32 |
| 2023-09-30 | $339k | 267k | 1.27 |
| 2023-06-30 | $4.8M | 1.4M | 3.29 |
| 2023-03-31 | $1.4M | 6.7k | 204.22 |
| 2022-12-31 | $2.3M | 387k | 5.86 |
| 2022-06-30 | $2.1M | 451k | 4.61 |
| 2022-03-31 | $1.3M | 310k | 4.05 |
| 2021-12-31 | $197k | 32k | 6.23 |
| 2021-03-31 | $2.3M | 142k | 16.18 |
| 2020-12-31 | $4.6M | 174k | 26.61 |
| 2020-09-30 | $3.9M | 207k | 18.80 |
| 2020-06-30 | $5.3M | 225k | 23.40 |
| 2020-03-31 | $2.6M | 447k | 5.82 |
| 2019-12-31 | $3.9M | 678k | 5.73 |
| 2019-09-30 | $1.5M | 929k | 1.57 |
| 2019-06-30 | $3.3M | 814k | 4.07 |
| 2019-03-31 | $4.3M | 823k | 5.26 |
| 2018-12-31 | $1.7M | 425k | 4.08 |
| 2018-09-30 | $3.2M | 318k | 10.00 |
| 2018-06-30 | $5.3M | 294k | 17.86 |
| 2018-03-31 | $4.9M | 308k | 15.78 |
| 2017-12-31 | $5.5M | 334k | 16.43 |
| 2017-06-30 | $4.8M | 341k | 13.97 |